Navigation Links
U.S. Panel Rejects Ovarian Cancer Screens for Low-Risk Women
Date:9/10/2012

By Amanda Gardner
HealthDay Reporter

MONDAY, Sept. 10 (HealthDay News) -- A leading U.S. government panel has recommended against ovarian cancer screening for women who are not at high risk for the disease.

The blood test and transvaginal ultrasound that are currently used to spot ovarian cancer may cause more harm than benefit for those patients, according to final guidelines issued Monday by the U.S. Preventive Services Task Force. Women who have the genetic mutations (BRCA1/BRCA2) or family histories that raise their chances of developing ovarian cancer should be referred for genetic testing and counseling, the recommendations add.

These latest guidelines, which were also published Sept. 11 in the Annals of Internal Medicine, mirror those set by the task force back in 2004.

"There is no existing method of screening for ovarian cancer that is effective in reducing deaths," Dr. Virginia Moyer, chair of the U.S. Preventive Services Task Force, said in a USPSTF statement issued Monday. "In fact, a high percentage of women who undergo screening experience false-positive test results and consequently may be subjected to unnecessary harms, such as major surgery," she said.

"In light of this, there is a critical need to develop better screening tests for ovarian cancer," Moyer added.

Experts agreed that effective tests to screen for ovarian cancer are desperately needed.

"It is very important that the population at large understands that screening with [ultrasound] and CA 125 is not beneficial at this time," said Dr. Diana Contreras, director of gynecologic oncology at Long Island Jewish Medical Center in New Hyde Park, N.Y. "It is clear new avenues need to be pursued, and women need to insist that more research is performed attempting to find an adequate screening mechanism so that ovarian cancer can be detected at a curable stage."

In addition, Dr. Elizabeth Poynor, a gynecolo
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Expert panel calls for new research approach to prevent youth violence
2. Expert Panel Suggests PSA Test May Benefit Some Men
3. Few Patients Should Get Metal-on-Metal Hip Implants, FDA Panel Says
4. Screen All Adults for Obesity: U.S. Panel
5. FDA Panel Backs At-Home HIV Test
6. FDA Panel to Consider At-Home HIV Test
7. FDA Panel Gives Blessing to New Weight-Loss Drug
8. U.S. Panel Rejects Ovarian Cancer Screening
9. Mechanisms of acquired chemoresistance in ovarian cancer identified
10. Benefit of PET and PET/CT in ovarian cancer is not proven
11. Ovarian Transplants May Preserve Fertility in Young Cancer Survivors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
U.S. Panel Rejects Ovarian Cancer Screens for Low-Risk Women 
(Date:2/27/2015)... (PRWEB) February 27, 2015 In honor of American ... Primary Care (CPC) South office, is offering tips on how to ... of death, but that doesn't mean people have to accept it ... some risk factors — such as family history, sex or age ... , Dr. Scott has six helpful tips to improve heart ...
(Date:2/27/2015)... 27, 2015 Royal River Natural Foods, a ... new study that found adults who got the most magnesium ... diabetes compared to those who got the least magnesium, with ... , The report is part of the March 2015 issue ... River Natural Foods publishes free each month for the Freeport ...
(Date:2/27/2015)... Daytona Beach, FL (PRWEB) February 27, 2015 ... marketing medical companies, devices and pharmaceuticals, Benedict Advertising ... FL as its newest client. The company’s patented ... is a pain-free, no-stress method of sedation. , ... taking medical patient comfort to a new level, ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 FACE ... therapies, has announced a unique combination to take ... neck. Ultherapy Décolletage is a new treatment introduced ... noninvasive procedure specifically indicated to improve lines and ... for any person who suffers from the stubborn ...
(Date:2/27/2015)... Nashville, TN (PRWEB) February 27, 2015 ... Oral Health, has announced a scholarship for rising freshmen ... is Nashville’s leading periodontist office specializing in many periodontal ... , and treatment of gum disease . In ... single $1,000 college scholarship for eligible rising freshmen undergraduate ...
Breaking Medicine News(10 mins):Health News:Center for Primary Care Celebrates American Heart Month 2Health News:Center for Primary Care Celebrates American Heart Month 3Health News:Center for Primary Care Celebrates American Heart Month 4Health News:New Study Finds Magnesium May Slow Progress of Diabetes, Retailer Reports 2Health News:Benedict Advertising & Marketing Signs Sedation Systems 2Health News:Face Skincare Announces New Combination Therapy 2Health News:Nashville Periodontist Office AIOH Announces 2015 Scholarship 2
... , , LOS ANGELES, Jan. 8 ... the following statement regarding Governor Schwarzenegger,s recommended cuts to ... 10-11 proposed budget today. , "The Governor,s proposed ... seniors, people with disabilities, and those who provide them ...
... , CLEVELAND, Jan. 8 RSB Spine, LLC, today announced ... 2009, versus year-end 2008, and a 42% sales increase for ... company reported that it achieved an important milestone in 2009 ... Chief Executive Officer John A. Redmond said: "We are obviously ...
... FRANCISCO, Jan. 8 Gloria Austin, Brown & Toland,s ... retire near the end of 2010. Austin informed the ... in September 2009 to allow sufficient time to begin ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20100108/SF34303 ) , Brown & ...
... , 4,000 Healthcare Workers Seek Vote ... to Stay United in SEIU , OAKLAND, Calif., Jan. ... 26 California hospitals and nursing homes are seeking elections to ... chosen to stay united in the Service Employees International Union ...
... , HAYWARD, Calif., Jan. 8 Solta Medical, Inc. ... aesthetics market, today announced that it will present at the ... Palace Hotel. The Company,s presentation is scheduled for 9:20 ... Fanning, Chairman, President and Chief Executive Officer, will review the ...
... , GILBERT, Ariz., Jan. 8 Gilbert Hospital ... 43,190 patient visits through the emergency department, patient levels remained ... to Doc in 31 Minutes" continued its success with more ... Board certified physician within 31 minutes of arrival. Additionally, the ...
Cached Medicine News:Health News:Response to Governor Schwarzenegger's Proposed FY10-11 Budget and Recommended Cuts to State's Homecare Program 2Health News:Gloria Austin, Brown & Toland's Chief Executive Officer, Announces Retirement 2Health News:Gloria Austin, Brown & Toland's Chief Executive Officer, Announces Retirement 3Health News:SEIU-UHW Members at 26 Hospitals and Nursing Homes Seeking Elections Against Group Started by the Union's Ousted Leaders 2Health News:SEIU-UHW Members at 26 Hospitals and Nursing Homes Seeking Elections Against Group Started by the Union's Ousted Leaders 3Health News:Solta Medical to Present at the 12th Annual Needham Growth Stock Conference 2Health News:Gilbert Hospital 2009 Emergency Department Year in Review 2
(Date:2/27/2015)... , Feb. 27, 2015  Pomerantz LLP is ... Inc. ("Vitae" or the "Company") (NASDAQ: VTAE ... S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ... and certain of its officers and/or directors have violated ... of 1934.  On February 27, 2015, ...
(Date:2/27/2015)... , Feb. 27, 2015 Securities lawyers ... board of Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP ... per share. Concerned SLXP investors are encouraged to contact ... The investigation focuses upon the shareholder value ... Salix shareholders would receive only $158.00 per share in ...
(Date:2/27/2015)... 27, 2015 Report Details   ... you trends, R&D progress, and predicted revenues ,Where is ... are the commercial prospects for this market and related ... and other trends to 2025, discussing data, opportunities and ... assess regenerative medicine : cell-based therapies that aim ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vitae Pharmaceuticals, Inc. - VTAE 2Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8
... 28 Preliminary results of a pre-specified subgroup ... that the investigational triple combination therapy of olmesartan medoxomil ... statistically significant greater Least Squares (LS) mean reduction in ... Hg versus 26.4-28.0/14.7-17.6 mm Hg, P less than or ...
... Mass. , June 28 Tolerx, Inc., ... diseases and cancer by modulating T cell activity, today ... trial to further evaluate otelixizumab in autoimmune new-onset type ... called DEFEND-2 (Durable-Response Therapy Evaluation For Early or New-Onset ...
Cached Medicine Technology:New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes 2New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes 3New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes 4New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes 5New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes 6New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes 7Tolerx Initiates Confirmatory Phase 3 Clinical Trial, DEFEND-2, with Otelixizumab for Type 1 Diabetes 2Tolerx Initiates Confirmatory Phase 3 Clinical Trial, DEFEND-2, with Otelixizumab for Type 1 Diabetes 3Tolerx Initiates Confirmatory Phase 3 Clinical Trial, DEFEND-2, with Otelixizumab for Type 1 Diabetes 4
2-ply material consisting of polyethylene film inner layer and non-woven outer layers....
Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and ...
The cardiac blanket is pre-positioned at the waist during prep, unrolled upon closure of the saphenous vein graft incision, and inflated post-bypass....
The full access underbody blanket is positioned on the procedure table before the patient arrives to the room....
Medicine Products: